Worship Street Investments increase their shareholding

The Board of Sutherland Health Group are pleased to report that the Board has been notified that a current shareholder Worship Street Investments Plc have increased their shareholding.

                                                                                                                                                  12 July 2010
                                                       SUTHERLAND HEALTH GROUP PLC
                                           (“Sutherland Health Group” or “the Company”)
                                                                PLUS Symbol: SHGP


Worship Street Investments Increase their Shareholding


The Board of Sutherland Health Group, a national supplier of patient hygiene, and sexual health products to customers including the NHS, are pleased to report that the Board has been notified that a current shareholder Worship Street Investments Plc have increased their shareholding by 300,000 shares taking their total shareholding to 6.75% of the Company as outlined in the Worship Street Investments Plc announcement of the 6 July 2010.


The Directors of the Issuer accept responsibility for this announcement.

Enquiries:


John French, Chairman
Sutherland Health Group plc
E: john@sutherlandhealth.com
T: 07836 722 482


Bridge Hall
Alex Benger
E: corpfin@bhcf.co.uk
T: 020 7337 9705


Bishopsgate Communications Ltd.
Maxine Barnes
E: shg@bishopsgatecommunications.com
T: 020 7562 3367


Notes to Editors:


Sutherland Health Group Plc is a national supplier of patient hygiene, sexual health and diagnostic products to the UK National Health Service (NHS) and other UK customers. Its aim is to supply innovative solutions to current health issues by studying current trends and working alongside leading professionals who also work within the health sector.


The company is committed to developing and marketing high quality brands and products that will benefit health professionals and consumers alike in many areas of health. The Group has established its own brands Condomania® Condoms, Sutherland® Lubricating Jelly and Vision® pregnancy diagnostics that have already become established within the NHS business.


The Company has also developed the Sutherland® patient hygiene range which is now on contract with NHS England and NHS Northern Ireland that can reduce the risk to patients of cross infection.


The Group is ISO and MHRA registered, and at present principally operates within the United Kingdom.
 

For further information on the Company visit www.sutherlandhealth.com

Latest news RSS

09/11/2017

Sutherland at Procurex Wales 2017

Sutherland at Procurex Wales 2017

29/06/2017

Final Results 30th September 2016

Sutherland Health Group Final Results September 2016

11/11/2016

Sutherland Attending European Midwives Conference

Sutherland Attending EMA Conference

Sign up

Subscribe

For further information, please read our Privacy Policy.